Papers on urine

1,292 papers66 new in 30 days

Monday, October 26

Journal of XenobioticsOct 26

Associations of Organophosphate Pesticide Metabolite Mixtures with Epigenetic Age Acceleration

Cross-sectional study of 427 peoplePopulations

Paper

ESC Congress 2026 AbstractOct 26

High blood sweetener levels linked to death risk in kidney disease

Death hazard ratios—comparisons of death rates over time—were 2.29 for erythritol and 1.99 for xylitol, comparing highest versus lowest blood-level quarters.Death hazard ratios—comparisons of death rates over time—were 2.29 for erythritol and 1.99 for xylitol, comparing highest versus lowest blood-level quarters.

Kidney cross-sections show heavy versus light scarring beside blood samples with dense versus sparse sweetener molecules.

Cohort · 5,143 peopleBiomarkers

Paper

ESC Congress 2026 AbstractOct 26

Dapagliflozin did not reduce heart chamber mass overall in dialysis

Over six months, heart chamber muscle mass, adjusted for body size, rose 4.5 grams per square meter with dapagliflozin versus 8.0 with placebo.Over six months, heart chamber muscle mass, adjusted for body size, rose 4.5 grams per square meter with dapagliflozin versus 8.0 with placebo.

Randomized trial · 142 peopleDapagliflozin

Paper

ESC Congress 2026 AbstractOct 26

Kidney tubular health biomarkers identify patients with impaired attainment of intensive blood pressure targets: results from the SPRINT trial

Study in peopleBiomarkers

Paper

ESC Congress 2026 AbstractOct 26

Finerenone with empagliflozin according to body mass index in chronic kidney disease and type 2 diabetes

Randomized trial in 800 peopleFinerenone

Paper

ESC Congress 2026 AbstractOct 26

Higher hs-CRP predicts severe cardiovascular-kidney-metabolic syndrome stages: The NHANES 2015 – 2018 survey cycle

Cross-sectional study of 8,986 peopleC-reactive protein

Paper

ESC Congress 2026 AbstractOct 26

Long-term cardiovascular outcomes across KDOKI risk categories in a large Asian cohort

Cohort study of 162,946 peopleBiomarkers

Paper

ESC Congress 2026 AbstractOct 26

Simultaneous versus sequential initiation of CKM therapies: an indirect comparison of CONFIDENCE and FIDELITY

Meta-analysis of randomized trialsInterventions

Paper

ESC Congress 2026 AbstractOct 26

Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1301, an oral PCSK9 inhibitor, in healthy participants: a first-in-human, randomized, double-blind, placebo-controlled phase I trial

Randomized trial in 83 peopleInterventions

Paper

JBMR PlusOct 26

Albuminuria, glomerular filtration rate, and fracture among U.S. adults with and without type 2 diabetes

Fracture prevalence in NHANES (1999-2020) by combined albuminuria, eGFR, and type 2 diabetes status.

Cross-sectional study of 20,034 peopleVertebral fracture

Paper

ESC Congress 2026 AbstractOct 26

Cardiovascular-kidney-metabolic overlap and finerenone in heart failure: insights from the FINEARTS-HF Trial

Trial in peopleInterventions

Paper

ESC Congress 2026 AbstractOct 26

Effect of SGLT2 inhibitors on changes in skeletal muscle index in patients participating in cardiac rehabilitation

Study of 40 peopleSGLT2 inhibitors

Paper

ESC Congress 2026 AbstractOct 26

Prognostic significance of low alanine aminotransferase in patients with transthyretin amyloid cardiomyopathy

Cohort study of 292 peopleAlanine aminotransferase

Paper

Sunday, October 25

Journal of the American Society of NephrologyOct 25

Empagliflozin was well tolerated in a kidney disease trial

In both groups, 96% tolerated the full dose; height-adjusted kidney volume grew 10.5% a year with empagliflozin versus 5.1% with placebo.In both groups, 96% tolerated the full dose; height-adjusted kidney volume grew 10.5% a year with empagliflozin versus 5.1% with placebo.

Kidney cutaways show a large dark blue-green kidney crowded with large cysts beside a smaller gray kidney with fewer, smaller cysts.

Randomized trial · 50 peopleEmpagliflozin

Paper

BMJ Public HealthOct 25

Ethnic differences in albuminuria and advanced chronic kidney disease among individuals with type 2 diabetes: a retrospective cohort study in South London

Predicted probability of advanced CKD by age (20–90 years) and ethnicity.

Cohort study of 26,298 peopleAlbuminuria

Paper

Heart Failure ReviewsOct 25

Diuretic therapy at the heart-kidney interface: from acute decongestion to long-term de-escalation in heart failure with reduced ejection fraction

ReviewHeart failure with reduced ejection fraction

Paper

Nephrology, Dialysis, TransplantationOct 25

Long-term cost-effectiveness of CKD screening in middle-aged adults

Computational studyChronic kidney disease

Paper

American Journal of HypertensionOct 25

The mediating role of sleep blood pressure in the association between B-type natriuretic peptide and cardiovascular events: The Nagahama Study

Cohort study of 5,751 peopleB-type natriuretic peptide

Paper

Saturday, October 24

Analytical ChemistryOct 24

Renal-Clearable Fluorogenic Nanoprobes for Molecular Imaging of Hepatic Drug-Metabolizing Cytochrome P450 2C19 Enzyme

Experiments in miceInterventions

Paper

Friday, October 23

Clinical RheumatologyOct 23

Higher urine protein ratio linked to osteoarthritis risk

Compared with normal readings, moderately and highly elevated urine ratios had osteoarthritis hazard ratios, relative risk measures, of 1.11 and 1.20 over nearly 18…Compared with normal readings, moderately and highly elevated urine ratios had osteoarthritis hazard ratios, relative risk measures, of 1.11 and 1.20 over nearly 18 years.